BCYC FY 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+23.6% YoY

Gross Profit

$14M100.0% margin

Operating Income

-$117M-806.6% margin

Net Income

-$113M-779.3% margin

EPS (Diluted)

$-3.80

Cash Flow

Operating Cash Flow

-$86M

Free Cash Flow

-$105M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$411M

Total Liabilities

$140M

Stockholders' Equity

$271M

Cash & Equivalents

$339M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$12M	+23.6%
Gross Profit	$14M	$12M	+23.6%
Operating Income	-$117M	-$66M	-77.8%
Net Income	-$113M	-$67M	-68.7%